Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic and mitral valves – an update on indications, techniques, and clinical results

References

• Baumgartner H, Falk V, Bax JJ, et al. ESC/EACTS Guidelines for the management of valvular heart disease. Eur Heart J. 2017;2017(38):2739–2791.
   Google Scholar
• Otto CM, Nishimura RA, Bonow RO, et al. 2020 ACC/AHA guideline for the management of patients with valvular heart disease: executive summary. J Am Coll Cardiol. 2021;77:450–500.
   PubMed Web of Science ®Google Scholar
• Gallo M, Demertzis S, Gerosa G, et al. Leaflet hypomobility after transcatheter aortic valve replacement: thrombosis or mechanical factors? A possible pathophysiological pattern. J Heart Valve Dis. 2017;26:9–11.
   PubMedGoogle Scholar
• Dvir D, Webb JG, Bleiziffer S, et al. Transcatheter aortic valve implantation in failed bioprosthetic surgical valves. J Am Med Assoc. 2014;312:162–170.
   PubMed Web of Science ®Google Scholar
• Phan K, Zhao DF, Wang N, et al. Transcatheter valve-in-valve implantation versus reoperative conventional aortic valve replacement: a systematic review. J Thorac Dis. 2016;8:E83–93.
   PubMed Web of Science ®Google Scholar
• Nalluri N, Atti V, Munir AB, et al. Valve in valve transcatheter aortic valve implantation (ViV-TAVI) versus redo-surgical aortic valve replacement (redo-SAVR): a systematic review and meta-analysis. J Interv Cardiol. 2018;31:661–671.
   PubMed Web of Science ®Google Scholar
• Simonato M, Dvir D. Transcatheter aortic valve replacement in failed surgical valves. Heart. 2019;105:S38–43.
   PubMed Web of Science ®Google Scholar
• Wenaweser P, Buellesfeld L, Gerckens U, et al. Percutaneous aortic valve replacement for severe aortic regurgitation in degenerated bioprosthesis: the first valve in valve procedure using the corevalve revalving system. Catheter Cardiovasc Interv. 2007;70:760–764.
   PubMed Web of Science ®Google Scholar
• Reul RM, Ramchandani MK, Reardon MJ. Transcatheter aortic valve-in-valve procedure in patients with bioprosthetic structural valve deterioration. Methodist DeBakey Cardiovasc J. 2017;13:132–141.
   PubMedGoogle Scholar
• Urena M, Vahanian A, Brochet E, et al. Current indications for transcatheter mitral valve replacement using transcatheter aortic valves: valve-in-valve, valve-in-ring, and valve-in-mitral annulus calcification. Circulation. 2021 Jan 12;143(2):178–196. Epub 2021 Jan 11. PMID: 33428433.
   PubMed Web of Science ®Google Scholar
• Webb JG, Dvir D. Transcatheter aortic valve replacement for bioprosthetic aortic valve failure: the valve-in-valve procedure. Circulation. 2013;127:2542–2550.
   PubMed Web of Science ®Google Scholar
• Smith CR, Leon MB, Mack MJ, et al. Transcatheter versus surgical aortic-valve replacement in high-risk patients. N Engl J Med. 2011;364:2187–2198.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Smith CR, et al. 5-year outcomes of transcatheter aortic valve replacement or surgical aortic valve replacement for high surgical risk patients with aortic stenosis (PARTNER 1): a randomised controlled trial. Lancet. 2015;385(9986):2477–2484.
   PubMed Web of Science ®Google Scholar
• Leon MB, Smith CR, Mack MJ, et al. Transcatheter or surgical aortic-valve replacement in intermediate-risk patients. N Engl J Med. 2016;374:1609–1620.
   PubMed Web of Science ®Google Scholar
• Makkar RR, Thourani VH, Mack MJ, et al. Five-year outcomes of transcatheter or surgical aortic-valve replacement. N Engl J Med. 2020;382:799–809.
   PubMed Web of Science ®Google Scholar
• Mack MJ, Leon MB, Thourani VH, et al. Transcatheter aortic-valve replacement with a balloon-expandable valve in low-risk patients. N Engl J Med. 2019;380:1695–1705.
   PubMed Web of Science ®Google Scholar
• Popma JJ, Deeb GM, Yakubov SJ, et al. Transcatheter aortic-valve replacement with a self-expanding valve in low-risk patients. N Engl J Med. 2019;380:1706–1715.
   PubMed Web of Science ®Google Scholar
• Kolte D, Vlahakes GJ, Palacios IF, et al. Transcatheter versus surgical aortic valve replacement in low-risk patients. J Am Coll Cardiol. 2019;74:1532–1540.
   PubMedGoogle Scholar
• Thyregod HGH, Steinbrüchel DA, Ihlemann N, et al. Transcatheter versus surgical aortic valve replacement in patients with severe aortic valve stenosis: 1-year results from the all-comers NOTION randomized clinical trial. J Am Coll Cardiol. 2015;65:2184–2194.
   PubMed Web of Science ®Google Scholar
• USFaD A. FDA expands indication for several transcatheter heart valves to patients at low risk for death or major complications associated with open-heart surgery [Internet]. 2019 [cited 2020 Dec 20]. Available from: https://www.fda.gov/news-events/press-announcements/fda-expands-indication-several-transcatheter-heart-valves-patients-low-risk-death-or-major
   Google Scholar
• Guerrero M, Salinger M, Pursnani A, et al. Transseptal transcatheter mitral valve-in-valve: a step by step guide from preprocedural planning to postprocedural care. Catheter Cardiovasc Interv. 2018;92:E185–96.
   PubMed Web of Science ®Google Scholar
• Foroutan F, Guyatt GH, O’Brien K, et al. Prognosis after surgical replacement with a bioprosthetic aortic valve in patients with severe symptomatic aortic stenosis: systematic review of observational studies. BMJ Online. 2016;354:1–9.
   Google Scholar
• Gallo M, Dvir D, Demertzis S, et al. Transcatheter valve-in-valve implantation for degenerated bioprosthetic aortic and mitral valves. Expert Rev Med Devices. 2016;13:749–758.
   PubMed Web of Science ®Google Scholar
• Gallo M, Gerosa G. Multiparameter approach to evaluate elderly patients undergoing aortic valve replacement. J Thorac Cardiovasc Surg. 2014;148:1749–1751.
   PubMed Web of Science ®Google Scholar
• Sullivan PG, Wallach JD, Ioannidis JPA. Meta-analysis comparing established risk prediction models (EuroSCORE II, STS score, and ACEF score) for perioperative mortality during cardiac surgery. Am J Cardiol. 2016;118:1574–1582.
   PubMed Web of Science ®Google Scholar
• Herrmann HC, Daneshvar SA, Fonarow GC, et al. Prosthesis–patient mismatch in patients undergoing transcatheter aortic valve replacement: from the STS/ACC TVT registry. J Am Coll Cardiol. 2018;72:2701–2711.
   PubMed Web of Science ®Google Scholar
• Silva D, Stripling JH, Hansen L, et al. Aortic valve replacement after transapical valve-in-valve implantation. Ann Thorac Surg. 2011;91:3–5.
   Web of Science ®Google Scholar
• Tanase D, Grohmann J, Schubert S, et al. Cracking the ring of Edwards Perimount bioprosthesis with ultrahigh pressure balloons prior to transcatheter valve in valve implantation. Int J Cardiol. 2014;176:1048–1049.
   PubMed Web of Science ®Google Scholar
• Nielsen-Kudsk JE, Christiansen EH, Jensen KT, et al. Images and case reports in interventional cardiology fracturing the ring of small mitroflow bioprostheses. Circ Cardiovasc Interv. 2015;8:1–5.
   Google Scholar
• Chhatriwalla AK, Allen KB, Saxon JT, et al. Bioprosthetic valve fracture improves the hemodynamic results of valve-in-valve transcatheter aortic valve replacement. Circ Cardiovasc Interv. 2017;10:e005216.
   PubMed Web of Science ®Google Scholar
• Ribeiro HB, Rodés-Cabau J, Blanke P, et al. Incidence, predictors, and clinical outcomes of coronary obstruction following transcatheter aortic valve replacement for degenerative bioprosthetic surgical valves: insights from the VIVID registry. Eur Heart J. 2018;39:687–695.
   PubMed Web of Science ®Google Scholar
• Regueiro A, Linke A, Latib A, et al. Association between transcatheter aortic valve replacement and subsequent infective endocarditis and in-hospital death. J Am Med Assoc. 2016;316:1083–1092.
   PubMed Web of Science ®Google Scholar
• Milburn K, Bapat V, Thomas M. Valve-in-valve implantations: is this the new standard for degenerated bioprostheses? Review of the literature. Clin Res Cardiol. 2014;103:417–429.
   PubMed Web of Science ®Google Scholar
• Bapat VN, Attia RQ, Condemi F, et al. Fluoroscopic guide to an ideal implant position for sapien XT and CoreValve during a valve-in-valve procedure. JACC Cardiovasc Interv. 2013;6:1186–1194.
   PubMed Web of Science ®Google Scholar
• Seiffert M, Franzen O, Conradi L, et al. Series of transcatheter valve-in-valve implantations in high-risk patients with degenerated bioprostheses in aortic and mitral position. Catheter Cardiovasc Interv. 2010;30(76):608–615.
   Google Scholar
• Blanke P, Weir-mccall JR, Achenbach S, et al. Computed tomography imaging in the context of transcatheter aortic valve implantation (TAVI)/transcatheter aortic valve replacement (TAVR). JACC Cardiovasc Imaging. 2019;12:1–24.
   PubMed Web of Science ®Google Scholar
• Hamid NB, Khalique OK, Monaghan MJ, et al. Transcatheter valve implantation in failed surgically inserted bioprosthesis. JACC Cardiovasc Imaging. 2015;8:960–979.
   PubMed Web of Science ®Google Scholar
• Cheung A, Webb JG, Barbanti M, et al. 5-year experience with transcatheter transapical mitral valve-in-valve implantation for bioprosthetic valve dysfunction. J Am Coll Cardiol. 2013;61:1759–1766.
   PubMed Web of Science ®Google Scholar
• Bapat V, Adams B, Attia R, et al. Neo-annulus: a reference plane in a surgical heart valve to facilitate a valve-in-valve procedure: neo-annulus of surgical heart valve. Catheter Cardiovasc Interv. 2015;85:685–691.
   PubMed Web of Science ®Google Scholar
• Tuzcu EM, Kapadia SR, Vemulapalli S, et al. Transcatheter aortic valve replacement of failed surgically implanted bioprostheses. J Am Coll Cardiol. 2018;72:370–382.
   PubMed Web of Science ®Google Scholar
• Lederman RJ, Babaliaros VC, Rogers T, et al. Preventing coronary obstruction during transcatheter aortic valve replacement. JACC Cardiovasc Interv. 2019;12:1197–1216.
   PubMed Web of Science ®Google Scholar
• Whisenant B, Kapadia SR, Eleid MF, et al. One-year outcomes of mitral valve-in-valve using the SAPIEN 3 transcatheter heart valve. JAMA Cardiol. 2020;5:1245.
   PubMed Web of Science ®Google Scholar
• Yoon S-H, Bleiziffer S, Latib A, et al. Predictors of left ventricular outflow tract obstruction after transcatheter mitral valve replacement. JACC Cardiovasc Interv. 2019;12:182–193.
   PubMed Web of Science ®Google Scholar
• Lisko JC, Greenbaum AB, Khan JM, et al. Antegrade intentional laceration of the anterior mitral leaflet to prevent left ventricular outflow tract obstruction: a simplified technique from bench to bedside. Circ Cardiovasc Interv. 2020;13:e008903.
   PubMed Web of Science ®Google Scholar
• Webb JG, Mack MJ, White JM, et al. Transcatheter aortic valve implantation within degenerated aortic surgical bioprostheses. J Am Coll Cardiol. 2017;69:2253–2262.
   PubMed Web of Science ®Google Scholar
• Webb JG, Murdoch DJ, Alu MC, et al. 3-year outcomes after valve-in-valve transcatheter aortic valve replacement for degenerated bioprostheses. J Am Coll Cardiol. 2019;73: 2647–255.
   Web of Science ®Google Scholar
• Deharo P, Bisson A, Herbert J, et al. Transcatheter valve-in-valve aortic valve replacement as an alternative to surgical re-replacement. J Am Coll Cardiol. 2020;76:489–499.
   PubMedGoogle Scholar
• Hirji SA, Percy ED, Zogg CK, et al. Comparison of in-hospital outcomes and readmissions for valve-in-valve transcatheter aortic valve replacement vs. reoperative surgical aortic valve replacement: a contemporary assessment of real-world outcomes. Eur Heart J. 2020;41:2747–2755.
   PubMed Web of Science ®Google Scholar
• Bleiziffer S, Simonato M, Webb JG, et al. Long-term outcomes after transcatheter aortic valve implantation in failed bioprosthetic valves. Eur Heart J. 2020;41:2731–2742.
   PubMed Web of Science ®Google Scholar
• Dy T, Dharma C, Rocha RV, et al. Transcatheter ViV versus redo surgical AVR for the management of failed biological prosthesis. JACC Cardiovasc Interv. 2020;13:765–774.
   PubMed Web of Science ®Google Scholar
• Tchétché D, Chevalier B, Holzhey D, et al. TAVR for failed surgical aortic bioprostheses using a self-expanding device. JACC Cardiovasc Interv. 2019;12:923–932.
   PubMed Web of Science ®Google Scholar
• Lee H-A, Chou A-H, Wu V-C-C, et al. Balloon-expandable versus self-expanding transcatheter aortic valve replacement for bioprosthetic dysfunction: a systematic review and meta-analysis. den Uil C, editor. PLOS ONE. 2020;15(6):e0233894.
   PubMed Web of Science ®Google Scholar
• Hamilton GW, Koshy AN, Fulcher J, et al. Meta-analysis comparing valve-in-valve transcatheter aortic valve implantation with self-expanding versus balloon-expandable valves. Am J Cardiol. 2020;125:1558–1565.
   PubMed Web of Science ®Google Scholar
• Mpbo S, Van den Eynde J, Simonato M, et al. Valve-in-valve transcatheter aortic valve replacement versus redo surgical aortic valve replacement. JACC Cardiovasc Interv. 2021;14:211–220.
   PubMed Web of Science ®Google Scholar
• Abdel-Wahab M, Simonato M, Latib A, et al. Clinical valve thrombosis after transcatheter aortic valve-in-valve implantation. Circ Cardiovasc Interv. 2018;11(11):e006730.
   PubMed Web of Science ®Google Scholar
• Cheung A, Webb JG, Wong DR, et al. Transapical transcatheter mitral valve-in-valve implantation in a human. Ann Thorac Surg. 2009;87:e18–20.
   PubMed Web of Science ®Google Scholar
• Simonato M, Whisenant B, Barbosa Ribeiro H, et al. Transcatheter mitral valve replacement after surgical repair or replacement: comprehensive mid-term evaluation of valve-in-valve and valve-in-ring implantation from the VIVID registry. Circulation. 2021;143:104–116.
   PubMed Web of Science ®Google Scholar
• Guerrero M, Vemulapalli S, Xiang Q, et al. Thirty-day outcomes of transcatheter mitral valve replacement for degenerated mitral bioprostheses (valve-in-valve), failed surgical rings (valve-in-ring), and native valve with severe mitral annular calcification (valve-in-mitral annular calcification) in the united states: data from the society of thoracic surgeons/american college of cardiology/transcatheter valve therapy registry. Circ Cardiovasc Interv. 2020;13:e008425.
   PubMed Web of Science ®Google Scholar
• Da Costa LPN, Palma JH, Barbosa Ribeiro H, et al. Transcatheter mitral valve-in-valve implantation: reports of the first 50 cases from a Latin American Centre. Interact Cardiovasc Thorac Surg. 2020;30:229–235.
   PubMed Web of Science ®Google Scholar
• Yoon S-H, Whisenant BK, Bleiziffer S, et al. Outcomes of transcatheter mitral valve replacement for degenerated bioprostheses, failed annuloplasty rings, and mitral annular calcification. Eur Heart J. 2019;40:441–451.
   PubMed Web of Science ®Google Scholar
• Joseph TA, Eleid MF, Cabalka AK, et al. Long‐term outcomes of melody valve‐in‐valve implantation for bioprosthetic mitral valve dysfunction. Catheter Cardiovasc Interv. 2019;93:1087–1094.
   PubMed Web of Science ®Google Scholar
• Kamioka N, Babaliaros V, Morse MA, et al. Comparison of clinical and echocardiographic outcomes after surgical redo mitral valve replacement and transcatheter mitral valve-in-valve therapy. JACC Cardiovasc Interv. 2018;11:1131–1138.
   PubMed Web of Science ®Google Scholar
• Urena M, Brochet E, Lecomte M, et al. Clinical and haemodynamic outcomes of balloon-expandable transcatheter mitral valve implantation: a 7-year experience. Eur Heart J. 2018;39:2679–2689.
   PubMed Web of Science ®Google Scholar
• Elmously A, Worku B, Gray KD, et al. Mitral valve-in-valve implantation as an elective or rescue procedure in high-risk patients. Ann Thorac Surg. 2018;105:1778–1783.
   PubMed Web of Science ®Google Scholar
• Eleid MF, Whisenant BK, Cabalka AK, et al. Early outcomes of percutaneous transvenous transseptal transcatheter valve implantation in failed bioprosthetic mitral valves, ring annuloplasty, and severe mitral annular calcification. JACC Cardiovasc Interv. 2017;10:1932–1942.
   PubMed Web of Science ®Google Scholar
• Simonetto F, Purita PAM, Malerba M, et al. Surgical redo versus transseptal or transapical transcatheter mitral valve‐in‐valve implantation for failed mitral valve bioprosthesis. Catheter Cardiovasc Interv. 2020 Oct 13:ccd.29324. DOI:10.1002/ccd.29324
   PubMed Web of Science ®Google Scholar
• Blanke P, Naoum C, Dvir D, et al. Predicting LVOT obstruction in transcatheter mitral valve implantation. JACC Cardiovasc Imaging. 2017;10:482–485.
   PubMed Web of Science ®Google Scholar
• Nielsen-Kudsk JE, Andersen A, Therkelsen CJ, et al. High-pressure balloon fracturing of small dysfunctional Mitroflow bioprostheses facilitates transcatheter aortic valve-in-valve implantation. EuroIntervention. 2017;13:e1020–1025.
   PubMed Web of Science ®Google Scholar
• Ye J, Lee AJ, Blanke P, et al. The first transapical transcatheter aortic valve-in-valve implantation using the J-valve system into a failed biophysio aortic prosthesis in a patient with high risk of coronary obstruction. Catheter Cardiovasc Interv. 2018;92:1209–1214.
   PubMed Web of Science ®Google Scholar
• Misfeld M, Abdel-Wahab M, Thiele H, et al. A series of four transcatheter aortic valve replacement in failed perceval valves. Ann Cardiothorac Surg. 2020;9:280–288.
   PubMed Web of Science ®Google Scholar
• Ferrari E, Gallo M, Wang C, et al. Three-dimensional printing in adult cardiovascular medicine for surgical and transcatheter procedural planning, teaching and technological innovation. Interact Cardiovasc Thorac Surg. 2020;30:203–214.
   PubMed Web of Science ®Google Scholar
• Foroutan F, Guyatt GH, Otto CM, et al. Structural valve deterioration after transcatheter aortic valve implantation. Heart. 2017;103:1899–1905.
   PubMed Web of Science ®Google Scholar
• Testa L, Latib A, Brambilla N, et al. Long-term clinical outcome and performance of transcatheter aortic valve replacement with a self-expandable bioprosthesis. Eur Heart J. 2020;41:1876–1886.
   PubMed Web of Science ®Google Scholar
• Schmidt T, Schlüter M, Alessandrini H, et al. Histology of debris captured by a cerebral protection system during transcatheter valve-in-valve implantation. Heart. 2016 Oct 1;102(19):1573–1580. Epub 2016 May 24. PMID: 27220695.
   PubMed Web of Science ®Google Scholar
• Gallo M, Putzu A, Conti M, et al. Embolic protection devices for transcatheter aortic valve replacement. Eur J Cardiothorac Surg. 2018 June 1;53(6):1118–1126. PMID: 29253108.
   PubMed Web of Science ®Google Scholar
• Barbanti M, Webb JG, Tamburino C, et al. Outcomes of redo transcatheter aortic valve replacement for the treatment of postprocedural and late occurrence of paravalvular regurgitation and transcatheter valve failure. Circ Cardiovasc Interv. 2016;9:e003930.
   PubMed Web of Science ®Google Scholar
• Pirelli L, Basman CL, Brinster DR, et al. Surgical resection of prosthetic valve leaflets under direct vision (SURPLUS) for Redo TAVR. JACC Cardiovasc Interv. 2021 May 10;14(9):1036–1037. Epub 2021 Apr 14. PMID: 33865740.
   PubMed Web of Science ®Google Scholar